We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Almost a year after Bayer settled pay-for-delay allegations involving its antibiotic Cipro, Allergan and Sanofi units have struck deals to resolve lingering Cipro claims in ongoing class action litigation, agreeing to pony up $100 million. Read More
Industry is praising the FDA for tackling both hiring and retention in its proposed goals for the next PDUFA, touting the proposals as necessary to support the agency’s initiatives. Read More
Gilead Sciences and Emory University have filed two lawsuits in U.S. District Court for the District of New Jersey against an India-based company over the patent rights to the HIV drug Truvada. One of the suits is related to two of the patents; another is related to all four patents. Read More